(Press-News.org) New research has uncovered immune changes in cancer patients that could help identify which patients are most at risk of dangerous heart complications from cancer drugs, known as immune checkpoint inhibitors.
The study was led by Assistant Professor Pilar Martín, Head of the Regulatory Molecules of Inflammation Lab at the Spanish National Center for Cardiovascular Research (CNIC) and group leader at CIBER-CV, she explained, “Immune checkpoint inhibitors have revolutionised cancer treatment, but they can also damage the hearts of some patients. In this study we monitored how levels of immune cells, that are known to be involved in the development of heart diseases, change after treatment.
“We were surprised to see an early and rapid loss of protective immune cells, called regulatory T cells, after cancer patients started treatment. This suggests a window of vulnerability early in treatment.” Assistant Professor Martin continued.
The new research is being presented at European Cardio-Oncology 2025, a scientific congress of the European Society of Cardiology.
Immune checkpoint inhibitors are drugs that work by harnessing the patient’s own immune response to attack cancer cells. Unfortunately, they can also have side-effects including causing heart damage, or cardiotoxicity, in some patients. Approximately 1 in 100 patients treated with these drugs develop myocarditis, a life-threatening heart complication.
Researchers found that patients with lower levels of a blood biomarker, called CD69 and found in protective immune cells, experienced a greater decrease in protective immune cells and a resulting increase in destructive pro-inflammatory immune cells. Such a decline in protective immune cells has previously been associated with a greater risk of developing cardiovascular complications such as myocarditis1.
“We put patients into two groups based on their levels of a protective biomarker called CD69, and saw these groups had very different response to the cancer treatments. Those who had lower levels of CD69 before starting treatment had a more negative immune response which puts them at much greater risk of heart damage.
“More work is needed to validate this biomarker and fully understand the immune changes that are taking place, but testing patients for this biomarker with a blood test is relatively cheap and easy and has the potential to help doctors identify which patients are at greatest risk of complications. This could allow doctors to monitor these patients more closely, and in time I hope we can develop new treatments to prevent the immune dysregulation we see in these patients” Professor Martin continued.
Researchers analysed blood samples from 215 cancer patients from the Spanish Immunotherapy Registry of Cardiovascular Toxicity (SIR-CVT)2 before treatment and at 24 weeks, 1012 weeks, 6 months, and 1 year after treatment with immune checkpoint inhibitors. The patients had a range of different cancers, including lung, breast and skin cancer, and were treated with different types of immune check point inhibitor treatments, including anti PD1, PDL1 and CTLA4.
Patients were put into two groups dependent the amount of biomarker for a specific protective T-cell (CD69) in their blood and changes in levels of their immune cell populations were monitored over time.
While both patient groups experienced some decline in levels of a specific type of a protective immune cell (CD69 positive regulatory T cells) in response to treatment, those patients with low starting levels of the protective biomarker had a much larger decrease. These patients also had an increase in immune cells with a role to kill other cells and others that have a role in inflammation.
Regulatory T cells are found in the blood and are important to maintain immune balance and stop the immune system damaging healthy tissues, including the heart and blood vessels. Previous research has shown how the wrong levels of these cells can result in damage to blood vessels and the heart, and this study suggests they could be key in mediating the heart damaging effects of immune checkpoint inhibitor cancer drugs.
-ENDS-
ESC Press Office
Tel: +33 6 61 40 18 84
Email: press@escardio.org
Follow us on X @ESCardioNews
Funding: This research was funded by the Spanish Society of Cardiology (SEC), the Spanish Society of Medical Oncology (SEOM), the National Center for Cardiovascular Research (CNIC), and the Madrid Regional Government (S2022/BMD-7209-INTEGRAMUNE-CM), the MCIN-ISCIII-Fondo de Investigación Sanitaria (PI22/01759), co-funded by the European Regional Development Fund, and by PMPTA22/00090-BIOCARDIOTOX, co-funded by NextGEN.
Disclosures: No disclosures
References and notes:
1. Cruz-Adalia A, Jiménez-Borreguero LJ, Ramírez-Huesca M, Chico-Calero I, Barreiro O, López-Conesa E, Fresno M, Sánchez-Madrid F, Martín P. CD69 limits the severity of cardiomyopathy after autoimmune myocarditis. Circulation. 2010 Oct 5;122(14):1396-404. doi: 10.1161/CIRCULATIONAHA.110.952820.
2. Zatarain-Nicolás E, Martín P, Márquez Rodas I, Virizuela J, Martín García A, Mitroi C, Cosín Sales J, Barrios V, Sánchez-Cabo F, Ibañez B, de Castro Carpeño J, López Fernández T. Cardiovascular toxicity of checkpoint inhibitors: review of associated toxicity and design of the Spanish Immunotherapy Registry of Cardiovascular Toxicity. Clin Transl Oncol. 2023 Nov;25(11):3073-3085. doi: 10.1007/s12094-023-03217-2. Epub 2023 May 25. PMID: 37227656.
About the European Society of Cardiology
The European Society of Cardiology brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.
About the ESC Council of Oncology
The ESC Council of Oncology is a multidisciplinary constituent body which encourages the prevention, early diagnosis and management of cancer therapy-related cardiovascular diseases.
Information for journalists about registration for ESC Cardio-Oncology 2025:
ESC Cardio-Oncology 2025 will take place in Florence, Italy, from Friday, 20 June to Saturday, 21 June 2025. Explore the scientific programme.
• Free registration applies to accredited press.
• For accreditation you need a valid press card or appropriate letter of assignment with proof of three recent published articles. Read also the ESC media and embargo policy.
• The ESC Press Office will verify the documents and confirm by email that your press accreditation is valid.
END
Mechanism behind life-threatening cancer drug side-effect revealed
2025-06-20
ELSE PRESS RELEASES FROM THIS DATE:
Weighted vests might help older adults meet weight loss goals, but solution for corresponding bone loss still elusive
2025-06-20
WINSTON-SALEM, N.C. – June 20, 2025 – A new randomized clinical trial, led by a team of researchers from Wake Forest University School of Medicine and Wake Forest University, did not find evidence that wearing a weighted vest or engaging in resistance training prevented bone loss in older adults undergoing intentional weight loss.
The study, published today in JAMA Network Open, underscores the persistent need for alternative strategies to protect skeletal health in aging populations with obesity.
While weight loss is commonly advised to enhance cardiovascular ...
Scientists find new way to predict how bowel cancer drugs will stop working – paving the way for smarter treatments
2025-06-20
Scientists have developed a tool that can predict how bowel cancer adapts to treatment – helping researchers to design new personalised drugs that will keep patients living well for longer.
A team from the Institute of Cancer Research, London, and Queen Mary University of London have designed a new technology that uses evolutionary biology to measure and predict how cancer cells will evolve when they are exposed to a new treatment.
Bowel cancer is the fourth most common cancer in the UK. There are around 44,100 new bowel cancer cases in the UK every year, or around 120 every day. Most bowel cancers are treated with chemotherapies and these treatments haven’t ...
Breast cancer patients’ microbiome may hold key to avoiding damaging heart side-effects of cancer therapies
2025-06-20
New research suggests that a healthy microbiome before chemotherapy could help protect breast cancer patients against heart damage, or cardiotoxicity, as a result of cancer therapy.
Researchers found that specific bacteria in patients’ gut microbiome correlated with heart health biomarkers that suggest they are at greater risk of heart damage during chemotherapy.
“To allow cancer survivors healthier lives, we need to find new ways to protect them from the long-term side-effects of chemotherapy. This study is one of the first to ask whether the microbiome could play a role in how well patient’s hearts fare during chemotherapy,” ...
Exercise-induced protein revives aging muscles and bones
2025-06-20
“Exercise is good for your health” is a well-known phrase, but few people can clearly explain how and why it benefits the human body.”
A joint research team, led by Dr. Yong Ryoul Yang of the Aging Convergence Research Group at the Korea Research Institute of Bioscience and Biotechnology (KRIBB, President: Seok-Yoon Kwon) and Professor Nak-Sung Kim of Chonnam National University, has discovered a key protein, CLCF1 (cardiotrophin-like cytokine factor 1), that plays a central role in mediating the health benefits of physical activity.
The team found that CLCF1 is secreted by muscles during exercise, where it helps strengthen both muscles and bones, thereby ...
American College of Cardiology issues guidance on weight management drugs
2025-06-20
The American College of Cardiology has issued a Concise Clinical Guidance (CCG) document to aid clinicians in the use of medication for weight management in patients where treatment may provide cardiovascular benefit.
Obesity is a chronic, progressive disease that affects over 1 billion people worldwide. It can lead to devastating cardiovascular complications, including increased risk of heart failure, coronary artery disease and stroke. It is also associated with a significant reduction in life expectancy (9.1 years ...
Understanding the effect of bedding on thermal insulation during sleep
2025-06-20
The temperature of our sleeping environment has a major impact on the quality of our sleep, and good sleep is essential for our overall health and well-being. The bedding micro-environment is a key factor in maintaining thermally comfortable conditions for sleep. This includes the ambient temperature, humidity, the heat generated by the human body, and the thermal insulation provided by bedding like quilts, blankets, sheets, etc.
In particular, the total thermal insulation, or the ability of the bedding systems to resist heat flow, ...
Cosmic signal from the very early universe will help astronomers detect the first stars
2025-06-20
Understanding how the universe transitioned from darkness to light with the formation of the first stars and galaxies is a key turning point in the universe’s development, known as the Cosmic Dawn. However, even with the most powerful telescopes, we can’t directly observe these earliest stars, so determining their properties is one of the biggest challenges in astronomy.
Now, an international group of astronomers led by the University of Cambridge have shown that we will be able to learn about the masses ...
With AI, researchers find increasing immune evasion in H5N1
2025-06-20
Highlights:
H5N1 avian influenza virus has been found in mammals and birds, and 1 person in the U.S. has died from an infection.
New work suggests that the virus is evolving new ways to evade human immune defenses.
Using artificial intelligence and physics-based modeling, the researchers found weakening binding between defensive antibodies and viral proteins.
The work shows how AI may help researchers understand how the virus is evolving and look for new antibodies or other therapeutic interventions.
Los Angeles, Calif.—The H5N1 avian influenza virus has infected birds and mammals around ...
Study finds hidden effects of wildfires on water systems
2025-06-20
Highlights:
Wildfires disrupt microbial communities on land, but also alter aquatic systems when dissolved organic matter on burnt lands is carried into rivers, lakes or drinking water supplies.
In a new study, researchers found that the impact of wildfires on water systems could lead to nutrient imbalances, depleting oxygen levels or harmful algal blooms.
More complex treatment methods may be needed to ensure impacted water is safe for consumption or recreation.
Los Angeles, Calif.—Wildfires profoundly influence the unseen microbial world within our waters, directly impacting water quality and ecosystem health, according to a new study ...
Airborne fungal spores may help predict COVID-19 & flu surges
2025-06-20
Highlights:
A new study identified that increased levels of fungal spores in the air were strongly linked to surges in cases of influenza and COVID-19.
Monitoring airborne fungal spores could help predict surges of respiratory virus infections, providing an early warning system to public health systems.
Los Angeles, Calif.—Monitoring fungal spores in the outdoor air can predict surges in flu and COVID-19 infections, especially during the fall, according to a new study. The study is presented at ASM Microbe ...